These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 23848131)

  • 1. Body mass index in patients with moderate-to-severe psoriasis in Spain and its impact as an independent risk factor for therapy withdrawal: results of the Biobadaderm Registry.
    Carrascosa JM; Vilavella M; Garcia-Doval I; Carretero G; Vanaclocha F; Daudén E; Gómez-García FJ; Herrera-Ceballos E; De la Cueva Dobao P; Belinchón I; Sánchez-Carazo JL; Alsina M; López-Estebaranz JL; Ferrán M; Peral F; Torrado R; Rivera R; Jiménez-Puya R; Mendiola MV; Ferrándiz C;
    J Eur Acad Dermatol Venereol; 2014 Jul; 28(7):907-14. PubMed ID: 23848131
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characteristics and risk profile of psoriasis patients included in the Czech national registry BIOREP and a comparison with other registries.
    Kojanova M; Fialova J; Cetkovska P; Gkalpakiotis S; Jircikova J; Dolezal T; Arenberger P;
    Int J Dermatol; 2017 Apr; 56(4):428-434. PubMed ID: 28181669
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of weight reduction on treatment outcomes in obese patients with psoriasis on biologic therapy: a randomized controlled prospective trial.
    Al-Mutairi N; Nour T
    Expert Opin Biol Ther; 2014 Jun; 14(6):749-56. PubMed ID: 24661040
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [BIOBADADERM, the Spanish Registry of Adverse Events Associated with Biologic Drugs in Dermatology: first report].
    Rivera R; García-Doval I; Carretero G; Daudén E; Sánchez-Carazo J; Ferrándiz C; Herrera E; Alsina M; Ferrán M; López-Estebaranz JL; Gómez F; Herranz JM; Carrascosa JM; Vanaclocha F;
    Actas Dermosifiliogr; 2011 Mar; 102(2):132-41. PubMed ID: 21377137
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adverse events associated with discontinuation of the biologics/classic systemic treatments for moderate-to-severe plaque psoriasis: data from the Spanish Biologics Registry, Biobadaderm.
    Belinchón I; Ramos JM; Carretero G; Ferrándiz C; Rivera R; Daudén E; De la Cueva-Dobao P; Gómez-García FJ; Herrera-Ceballos E; Sánchez-Carazo JL; López-Estebaranz JL; Alsina M; Ferrán M; Torrado R; Carrascosa JM; Llamas-Velasco M; Ortiz PL; García-Doval I; Descalzo MA;
    J Eur Acad Dermatol Venereol; 2017 Oct; 31(10):1700-1708. PubMed ID: 28485816
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Latent tuberculosis infection and active tuberculosis in patients with psoriasis: a study on the incidence of tuberculosis and the prevalence of latent tuberculosis disease in patients with moderate-severe psoriasis in Spain. BIOBADADERM registry.
    Sánchez-Moya AI; García-Doval I; Carretero G; Sánchez-Carazo J; Ferrandiz C; Herrera Ceballos E; Alsina M; Ferrán M; López-Estebaranz JL; Gómez-García F; De la Cueva Dobao P; Carrascosa JM; Vanaclocha F; Belinchón I; Peral F; Dauden E;
    J Eur Acad Dermatol Venereol; 2013 Nov; 27(11):1366-74. PubMed ID: 23134268
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between obesity measured by different parameters and severity of psoriasis.
    Duarte GV; Oliveira Mde F; Cardoso TM; Follador I; Silva TS; Cavalheiro CM; Nonato W; Carvalho EM
    Int J Dermatol; 2013 Feb; 52(2):177-81. PubMed ID: 22998685
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of overweight and obesity on psoriasis patients in Chinese Han population: a hospital-based study.
    Zhang C; Zhu KJ; Zheng HF; Cui Y; Zhou FS; Chen YL; Tang XF; Li M; Zhang FY; Fan X; Zuo XB; Yang S; Sun LD; Zhang XJ
    J Eur Acad Dermatol Venereol; 2011 Jan; 25(1):87-91. PubMed ID: 20477922
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety of classic and biologic systemic therapies for the treatment of psoriasis in elderly: an observational study from national BIOBADADERM registry.
    Medina C; Carretero G; Ferrandiz C; Dauden E; Vanaclocha F; Gómez-García FJ; Herrera-Ceballos E; De la Cueva-Dobao P; Belinchón I; Sánchez-Carazo JL; Alsina M; López-Estebaranz JL; Ferrán M; Carrascosa JM; Torrado R; Argila D; Rivera R; Jiménez-Puya R; García-Doval I;
    J Eur Acad Dermatol Venereol; 2015 May; 29(5):858-64. PubMed ID: 25185962
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of obesity and smoking on psoriasis presentation and management.
    Herron MD; Hinckley M; Hoffman MS; Papenfuss J; Hansen CB; Callis KP; Krueger GG
    Arch Dermatol; 2005 Dec; 141(12):1527-34. PubMed ID: 16365253
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Paradox of obesity in heart failure: results from the Spanish RICA Registry].
    Trullàs JC; Formiga F; Montero M; Conde A; Casado J; Carrasco FJ; Díez J; Ceresuela LM;
    Med Clin (Barc); 2011 Dec; 137(15):671-7. PubMed ID: 21719051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of body mass index on maternal and neonatal outcomes: a retrospective study in a UK obstetric population, 2004-2011.
    Scott-Pillai R; Spence D; Cardwell CR; Hunter A; Holmes VA
    BJOG; 2013 Jul; 120(8):932-9. PubMed ID: 23530609
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Description of Patients Treated with Biologic Drugs as First-Line Systemic Therapy in the BIOBADADERM Registry Between 2008 and 2016.
    Carretero Hernández G; Ferrándiz C; Rivera Díaz R; Daudén Tello E; de la Cueva-Dobao P; Gómez-García FJ; Herrera-Ceballos E; Belinchón Romero I; López-Estebaranz JL; Alsina Gibert M; Sánchez-Carazo JL; Ferrán Farrés M; González Quesada A; Carrascosa Carrillo JM; Llamas-Velasco M; Mendiola Fernández MV; Ruiz Genao D; Muñoz Santos C; García-Doval I; Descalzo MA;
    Actas Dermosifiliogr (Engl Ed); 2018 Sep; 109(7):617-623. PubMed ID: 29887167
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation between BMI and PASI in patients affected by moderate to severe psoriasis undergoing biological therapy.
    Bardazzi F; Balestri R; Baldi E; Antonucci A; De Tommaso S; Patrizi A
    Dermatol Ther; 2010; 23 Suppl 1():S14-9. PubMed ID: 20136916
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is there any survival advantage of obesity in Southern European haemodialysis patients?
    Chazot C; Gassia JP; Di Benedetto A; Cesare S; Ponce P; Marcelli D
    Nephrol Dial Transplant; 2009 Sep; 24(9):2871-6. PubMed ID: 19369686
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiovascular risk factors and cardiovascular diseases in patients with moderate to severe psoriasis under systemic treatment. PSO-RISK, descriptive study.
    Vanaclocha F; Belinchón I; Sánchez-Carazo JL; Rivera R; Carrascosa JM; Cea-Calvo L; Juliá B; Puig L
    Eur J Dermatol; 2014; 24(6):662-9. PubMed ID: 25333326
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Effectiveness of Guselkumab by BMI Category Among Patients with Moderate-to-Severe Plaque Psoriasis in the CorEvitas Psoriasis Registry.
    Armstrong AW; Fitzgerald T; McLean RR; Teeple A; Uy JP; Olurinde M; Rowland K; Guo L; Shan Y; Callis Duffin K
    Adv Ther; 2023 May; 40(5):2493-2508. PubMed ID: 36930429
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of Obesity in Patients with Psoriasis: Results of the National Study PsoHealth3.
    Jacobi A; Langenbruch A; Purwins S; Augustin M; Radtke MA
    Dermatology; 2015; 231(3):231-8. PubMed ID: 26202333
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Moderate to Severe Psoriasis in Pediatric and Young Patients: The BIOBADADERM Registry Experience.
    Nieto Benito LM; Carretero G; Rivera-Díaz R; Carrascosa JM; Daudén E; de la Cueva P; Sahuquillo-Torralba A; Herrera-Acosta E; Baniandrés-Rodríguez O; Lopez-Estebaranz JL; Belinchón I; Riera-Monroig J; Ferrán M; Gómez-García FJ; Mateu A; Rodríguez L; Vilar-Alejo J; García-Donoso C; Ballescá F; Velasco LM; Botella-Estrada R; Herrera-Ceballos E; Ruiz-Genao DP; Descalzo MA; García-Doval I;
    Actas Dermosifiliogr; 2022 Apr; 113(4):401-406. PubMed ID: 35428502
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of body mass index and obesity on clinical response to systemic treatment for psoriasis. Evidence from the Psocare project.
    Naldi L; Addis A; Chimenti S; Giannetti A; Picardo M; Tomino C; Maccarone M; Chatenoud L; Bertuccio P; Caggese E; Cuscito R
    Dermatology; 2008; 217(4):365-73. PubMed ID: 18810241
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.